p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy

Francisco Triana-Martinez,Alessandra Pierantoni,Daisy Graca,Veronica Bergo,Alexander Emelyanov,Bogdan Grigorash,Shunya Tsuji,Sosuke Nakano,Laurent Grosse,Vesna Brglez,Pierre Marty,Jean Dellamonica,Albert J Fornace,Eirini Trompouki,Hara Eiji,Barbara Seitz-Polski,Dmitry V Bulavin

DOI: https://doi.org/10.1101/2024.07.15.603540

2024-07-15

Abstract:The ability of an organism to overcome infectious diseases has traditionally been linked to killing invading pathogens. Accumulating evidence, however, indicates that, apart from restricting pathogen loads, organismal survival is coupled to an additional yet poorly understood mechanism called disease tolerance. Here we report that p16High immune cells play a key role in establishing disease tolerance. We found that the FDA-approved BNT162b2 mRNA COVID-19 vaccine is a potent and rapid inducer of p16High immune subsets both in mice and humans. In turn, p16High immune cells were indispensable for counteracting different lethal conditions, including LPS-induced sepsis, acute SARS-CoV-2 infection and ionizing irradiation. Mechanistically, we propose that activation of TLR7 or a low physiological activity of STING is sufficient to induce p16High immune subset that, in turn, establishes a low adenosine environment and disease tolerance. Furthermore, containing these signals within a beneficial range by deleting MDA5 that appeared sufficient to maintain a low activity of STING, induces p16High immune cells and delays organ deterioration upon aging with improved healthspan. Our data highlight the beneficial role of p16High immune subsets in establishing a low adenosine environment and disease tolerance.

Cell Biology

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

The paper attempts to explore the **key role of p16High immune cells in disease tolerance**. Specifically, the study finds:

1. **The relationship between the accumulation of p16High immune cells and aging and inflammation**:
- Researchers observed through a transgenic mouse model (p16-Cre/R26-mTmG) that the number of p16High immune cells significantly increases with age in different tissues.
- These cells are present not only in short-lived neutrophils but also in long-lived tissue-resident macrophages, constituting an important proportion of all p16High cells.

2. **The role of p16High immune cells in disease tolerance**:
- Traditionally, overcoming infectious diseases is thought to rely on killing invading pathogens, but the study finds that, in addition to limiting pathogen load, survival is also related to a mechanism called "disease tolerance."
- The authors propose that p16High immune cells are one of the key mechanisms in establishing disease tolerance.

3. **The impact of the BNT162b2 mRNA COVID-19 vaccine on p16High immune cells**:
- The BNT162b2 mRNA COVID-19 vaccine can rapidly induce p16High immune cell subsets in both mice and humans.
- This vaccine induces p16High immune cells by activating the TLR7 signaling pathway, thereby providing protection in situations such as acute inflammation, SARS-CoV-2 infection, and radiation damage.

Through these studies, the authors reveal the important role of p16High immune cells in establishing a low-adenosine environment and disease tolerance, providing new insights into how the body responds to infections and tissue damage.